Also, HHS announces support of vaccine development and capacity.
President Obama yesterday signaled he would veto a $1.1 billion Zika funding bill passed by the House of Representatives before they adjourned for the 4th of July break, Reuters reported. He said he objects to the deal reached through House and Senate conferencing because it is well short of the $1.9 billion the administration requested back in February.
Studies bring bad news and good: that earlier dengue infection can worsen Zika infections, but an antibody against dengue can also neutralize the Zika virus.
In other research news, CRISPR screening identifies possible drug targets.
Also, agencies publish guidance on Olympics travel and lab testing, and New York City officials outline their Zika response.
Inovio Pharmaceuticals will launch a phase 1 clinical trial of a DNA-based vaccine.
The World Health Organization (WHO) today announced the rollout of an updated strategy to fight Zika virus, covering response steps over the next 18 months. It said it needs $121.9 million to carry out the strategy.
The same test is in use at a Houston-area blood center, with some others facilities in the southern United States planning to start testing.
The CDC notes 6 instances of Zika-linked birth defects, 3 involving live births.
All 4 babies with microcephaly were born to asymptomatic women.
